Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
A conversation about early childhood development and ADHD symptoms with Hanna Gustafsson, Ph.D. and Elinor Sullivan, Ph.D.
2
Once-weekly pemvidutide begins phase 3 trial for MASH
3
Avalere Health’s Eric Levine, M.P.H., on what stakeholders can do so people don’t lose coverage because of the Medicaid work requirements
4
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1
5